|
Cisplatin (CIS) versus cetuximab (CET) with definitive concurrent radiotherapy (RT) for head and neck squamous cell carcinoma (HNSCC): An analysis of veteran’s health data. |
|
|
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech; Guardant Health; Merck |
Research Funding - Bayer (Inst); Carevive Systems (Inst); Incyte (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst) |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Cerulean Pharma |
Patents, Royalties, Other Intellectual Property - Very small amount of royalties from the federal government from a long-standing agreement on taxol. This has now ended. |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Genentech; Lilly |
Research Funding - Genentech/Roche (Inst); Incyte (Inst); Macrogenics (Inst); Merck Sharp & Dohme (Inst) |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Daiichi Sankyo (I); Sirtex Medical |
Consulting or Advisory Role - Amgen; Bayer; Celgene |
|
|
Honoraria - Bristol-Myers Squibb; Genentech/Roche; Lilly/ImClone |
Consulting or Advisory Role - Abbott Biotherapeutics; ARIAD; AstraZeneca; Bayer/Onyx; Bristol-Myers Squibb; Cancer Support Community; Celgene; Clarient; Clovis Oncology; Genentech/Roche; Lilly/ImClone; Merck; Takeda |
Research Funding - Advantagene (Inst); Ariad (Inst); Celgene (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Inovio Pharmaceuticals (Inst); Merck (Inst); Stem CentRx (Inst) |
Other Relationship - Amgen; Lilly; Peregrine Pharmaceuticals; Synta |
|
|
Honoraria - Bristol-Myers Squibb |
Consulting or Advisory Role - Cerulean Pharma; Heat Biologics; Kolltan Pharmaceuticals; Pfizer; Takeda; Zymeworks |
Research Funding - Celldex (Inst); Cleave Biosciences (Inst); Heat Biologics (Inst); Macrogenics (Inst); Merck (Inst); Takeda (Inst) |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Cerulean Pharma; Heat Biologics; Kolltan Pharmaceuticals; Pfizer; Takeda; Zymeworks |
|
|
No Relationships to Disclose |